Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasdaq
MedTech
Adagio Medical picks up the tempo with $128M SPAC deal
After operating at a slow-and-steady pace for a little over a decade, Adagio Medical is preparing to move to a new rhythm.
Andrea Park
Feb 15, 2024 1:40pm
Metagenomi, Telomir offer double test case for preclinical IPOs
Feb 9, 2024 7:00am
Kyverna overshoots raised IPO expectations with $319M offering
Feb 8, 2024 8:24am
Medicenna shifts to Toronto state of mind, Nasdaq listing lapses
Oct 27, 2023 10:26am
Abpro inks SPAC deal to fund bispecific R&D years after axed IPO
Sep 22, 2023 9:20am
RayzeBio scores $311M oversized IPO, Neumora hits $250M target
Sep 15, 2023 8:48am